SENETEK Sample Clauses

SENETEK hereby confirms that it has the expertise necessary to make use of any licensed patents and to develop, make, have made, sell, use, and otherwise commercially exploit the PRODUCTS.
AutoNDA by SimpleDocs
SENETEK agrees to make reasonable efforts to make, have made, sell and otherwise commercially exploit the PRODUCTS, using similar efforts devoted to products of similar nature and similar markets.
SENETEK. POSTAL ADDRESS 000 Xxxxxxx Xxxx, Xxxx, XX 00000 STREET ADDRESS 000 Xxxxxxx Xxxx, Xxxx, XX 00000 XXXXXXXXX XX 0 000000 0000 XXXXXXXXX NO 0 000000 0000 CONTACT PERSON Andreas Xxxxxx XXXXXXX POSTAL ADDRESS XX Xxx 00000, Xxxxxxxx 8 XXXXXX XXXXXXX Xxxxxxx Xxxx Xxxxx, Xxxxxxx, Xxxxxxxx TELEPHONE NO 00649 835 0660 FACSIMILE NO 00000 000 0000 CONTACT PERSON Xxxxxxx Sierrnans DEVELOPMENT AND DISTRIBUTION AGREEMENT PRODUCT TRADE MARKS Invicorp 2 (1) InvicorpTM
SENETEK hereby confirms that it has the expertise necessary to make use of any licensed patents and to develop, make, have made, sell, use, and otherwise commercially exploit the PRODUCTS. Phloretamide
SENETEK. (i) Senetek represents and warrants that it is not in default of any term, provision or condition of the Basic Agreement/License and that its rights thereunder are not encumbered in any manner, and the Cell Line Products are free of any claims for infringement, patent or copyrights and trademarks of third parties. Senetek also represents and warrants that there is no litigation, claim or assessment pending or threatened against Senetek contesting Senetek's rights under the Basic Agreement/License. Senetek hereby indemnifies and will hold Signet harmless from any and all costs, expenses, claims, attorney's fees and so forth in regard to all matters which have transpired prior to the execution of this Agreement now known or hereafter arising from the Basic Agreement/License, including, but not limited to, any and all claims from RFMH. (ii) Senetek represents and warrants that it will terminate its Manufacturing and Distribution Agreement with Covance Research Products, Inc. dated September 24, 1999 in accordance with the terms of said Agreement, and that there is no litigation, claim or assessment pending or threatened against Senetek on account thereof. Senetek will consult with Signet on the timing of the thirty (3) day notice of termination required thereunder. (iii) Senetek has complied with the terms and conditions of the Basic Agreement/License, including, but not limited to, all notice requirements and has received all of the necessary approvals from RFMH regarding the execution of this Agreement, including without limitation under Section 2.4 of the Basic Agreement/License, to engage Signet to manufacture, package, promote and sell the Cell Line Products. Copies of all such approvals in form satisfactory to Signet will be delivered to Signet simultaneously with the execution of this
SENETEK. (i) Senetek warrants and represents to Signet that it is not, and shall not hold itself out as, the representative, agent, servant or employee of Signet for any purpose. This Agreement creates no relationship of joint venture, partnership, limited partnership, or agency between the parties. (ii) Senetek represents and warrants that the execution of this Agreement by Senetek has been duly authorized by all necessary corporate action of Senetek and constitutes the valid and binding obligation of Senetek. The execution of this Agreement by Senetek and the consummation of the transactions contemplated hereby does not conflict with or result in a default under or breach of, (1) Senetek’s Certificate of Incorporation or Articles of Association or other organizational documents; (2) any agreement, indenture, mortgage, contract or instrument to which Senetek is bound or by which any of its properties or assets is subject; (3) any order, writ, injunction, decree or judgment of any court or governmental agency applicable to Senetek or to which any of its assets is bound; or (4) any law or regulation applicable to Senetek or by which any of its assets is bound. (iii) Senetek represents that the Cell Line Products, (1) are the sole property and confidential information of RFMH; (2) are subject to confidentiality requirements under the Basic Agreement/License and Extension which requirements also bind Senetek; and (3) may be transferred only back to Senetek or RFMH in accordance with the terms and requirements of the Basic Agreement/License and Extension. (iv) Senetek represents and warrants that it is not in default of any term, provision or condition of the Basic Agreement/License and the Extension and that its rights thereunder are not encumbered in any manner, and that to the best of Senetek’s knowledge the Cell Line Products are free of any claims for infringement, patent, copyrights and trademarks of third parties. Senetek also represents and warrants that there is no litigation, claim or assessment pending or threatened against Senetek contesting Senetek’s rights under the Basic Agreement/License and the Extension. Senetek hereby indemnifies and will hold Signet harmless from any and all costs, expenses, claims, attorney’s fees and so forth in regards to acts or omissions on Senetek’s part prior to the execution of this Agreement now known or hereafter arising from the Basic Agreement/License and the Extension, including, but not limited to, any and all claims f...
AutoNDA by SimpleDocs
SENETEK shall, starting with the effective date of this Agreement and again on each Anniversary Date, until termination, pay to RFMH a license maintenance fee of *** for each cell line licensed and shipped to LICENSEE. Said payments are non-refundable but are fully creditable against royalties.
SENETEK agrees to make reasonable efforts to commercially exploit the TREATMENT, using similar efforts devoted to products of similar nature and similar markets.

Related to SENETEK

  • Licensee “Licensee” means the individual or company that has entered into an Agreement with the Embassy. “Offer” means a response to a solicitation that, if accepted, would bind the offeror to perform the resultant Agreement.

  • Licensor any Person from whom a Grantor obtains the right to use any Intellectual Property. Lien: any Person’s interest in Property securing an obligation owed to, or a claim by, such Person, whether such interest is based on common law, statute or contract, including liens, security interests, pledges, hypothecations, statutory trusts, reservations, exceptions, encroachments, easements, rights-of-way, covenants, conditions, restrictions, leases, and other title exceptions and encumbrances affecting Property. Lien Waiver: an agreement, in form and substance satisfactory to Agent, by which (a) for any material Collateral located on leased premises, the lessor waives or subordinates any Lien it may have on the Collateral, and agrees to permit Agent to enter upon the premises and remove the Collateral or to use the premises to store or dispose of the Collateral; (b) for any Collateral held by a warehouseman, processor, shipper, customs broker or freight forwarder, such Person waives or subordinates any Lien it may have on the Collateral, agrees to hold any Documents in its possession relating to the Collateral as agent for Agent, and agrees to deliver the Collateral to Agent upon request; (c) for any Collateral held by a repairman, mechanic or bailee, such Person acknowledges Agent’s Lien, waives or subordinates any Lien it may have on the Collateral, and agrees to deliver the Collateral to Agent upon request; and (d) for any Collateral subject to a Licensor’s Intellectual Property rights, the Licensor grants to Agent the right, vis-à-vis such Licensor, to enforce Agent’s Liens with respect to the Collateral, including the right to dispose of it with the benefit of the Intellectual Property, whether or not a default exists under any applicable License.

  • Cardiff Capital Region has secured a deal worth £1.2 billion. Over its lifetime, local partners expect the City Deal to deliver up to 25,000 new jobs and leverage an additional £4 billion of private sector investment.

  • Distributor The Trust hereby appoints the Distributor as general distributor of shares of beneficial interest (“Series shares”) of the Trust’s WCM Funds series (the “Series”) during the term of this Agreement. The Trust reserves the right, however, to refuse at any time or times to sell any Series shares hereunder for any reason deemed adequate by the Board of Trustees of the Trust.

  • API If the Software offers integration capabilities via an API, your use of the API may be subject to additional costs or Sage specific policies and terms and conditions (which shall prevail in relation to your use of the API). You may not access or use the API in any way that could cause damage to us or the Software, or in contravention of any applicable laws. We reserve the right in our sole discretion, to: (i) update any API from time to time; (ii) place limitations around your use of any API; and (iii) deny you access to any API in the event of misuse by you or to otherwise protect our legitimate interests.

  • Transnet (i) For legal notices: …………………………………………………… …………………………………………………… …………………………………………………… Fax No. ………… Attention: Group Legal Department (ii) For commercial notices: …………………………………………………… …………………………………………………… …………………………………………………… Fax No. ………… Attention: …………

  • Cornerstone shall notify the LLC and confirm such advice in writing (i) when the filing of any post-effective amendment to the Registration Statement or supplement to the Prospectus is required, when the same is filed and, in the case of the Registration Statement and any post-effective amendment, when the same becomes effective, (ii) of any request by the Securities and Exchange Commission for any amendment of or supplement to the Registration Statement or the Prospectus or for additional information and (iii) of the entry of any stop order suspending the effectiveness of the Registration Statement or the initiation or threatening of any proceedings for that purpose, and, if such stop order shall be entered, Cornerstone shall use its best efforts promptly to obtain the lifting thereof.

  • Povinnosti Site and Institution’s personnel, including Study Staff shall not Místo provádění klinického hodnocení a zaměstnanci Zdravotnického zařízení, a to včetně Studijního personálu, nebudou

  • University Any notice may be served upon the University by delivering it, in writing, to the University at the address set forth on the last page of this Agreement, by depositing it in a United States Postal Service deposit box with the postage fully prepaid and with the notice addressed to the University at the aforementioned address, or by sending a facsimile of it to the University facsimile number set forth on the last page of this Agreement.

  • Middle School At the request of the Superintendent, a middle school teacher may volunteer on a semester basis to teach all the student contact time and be paid one-sixth (1/6) of his/her salary for the semester. This section shall not be used to circumvent the hiring of additional full time teachers.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!